<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="124403">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01483027</url>
  </required_header>
  <id_info>
    <org_study_id>TS-102</org_study_id>
    <nct_id>NCT01483027</nct_id>
  </id_info>
  <brief_title>Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer</brief_title>
  <acronym>EPOCH</acronym>
  <official_title>A Phase III Clinical Trial Evaluating TheraSphere® in Patients With Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BTG International Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biocompatibles UK Ltd</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>BTG International Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effectiveness and safety of TheraSphere will be evaluated in patients with colorectal
      cancer with metastases in the liver, who are scheduled to receive second line chemotherapy.
      All patients receive the standard of care chemotherapy with or without the addition of
      TheraSphere.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Progression free survival</measure>
    <time_frame>From date of randomization until the date of first documented progression or date of death from any cause, whichever comes first, assessed up to 36 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">340</enrollment>
  <condition>Colorectal Cancer Metastatic</condition>
  <arm_group>
    <arm_group_label>Treatment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard of care second-line chemotherapy plus TheraSphere</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care second-line chemotherapy with no added therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TheraSphere</intervention_name>
    <description>yttrium 90 microspheres</description>
    <arm_group_label>Treatment group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Must be male or female, 18 years of age or older, and of any ethnic or racial group

          -  Not resected primary tumor; must be clinically stable

          -  Colorectal cancer with unresectable metastatic disease to the liver (unresectable
             unilobar or bilobar disease) who have disease progression in the liver with
             oxaliplatin or irinotecan based first line chemotherapy

          -  Eligible to receive second-line standard-of-care chemotherapy with either 1) an
             oxaliplatin-based chemotherapy regimen, or 2) an irinotecan-based chemotherapy
             regimen

          -  Baseline efficacy images with measurable target tumors in the liver according to
             RECIST 1.1 using standard imaging techniques taken within 28 days prior to
             randomization. Images must be taken after, or at the time of completion of first line
             chemotherapy

          -  Tumor replacement &lt;50% of total liver volume

          -  Eastern Cooperative Oncology Group (ECOG) of 0-1 through screening to first treatment

          -  First line chemotherapy regimen completed at least 14 days prior to initiation of 2nd
             line chemotherapy under the protocol

          -  Patient is willing to participate in the study and has signed the study informed
             consent

          -  Serum creatinine ≤ 2.0 mg/dL

          -  Serum bilirubin up to 1.2 x upper limit of normal

          -  Albumin ≥ 3.0 g/dL

          -  Neutrophil count &gt;1200/cubic mm

        Exclusion Criteria

          -  History of hepatic encephalopathy

          -  Contraindications to angiography and selective visceral catheterization such as
             bleeding diathesis or coagulopathy that is not correctable by usual therapy of
             hemostatic agents

          -  History of severe peripheral allergy or intolerance to contrast agents, narcotics,
             sedatives or atropine that cannot be managed medically

          -  Presentation of pulmonary insufficiency or clinically evident chronic obstructive
             pulmonary disease

          -  Cirrhosis or portal hypertension

          -  Prior external beam radiation treatment to the liver

          -  Prior intra-arterial liver directed therapy, including transcatheter arterial
             chemoembolization (TACE) or Y-90 microsphere therapy

          -  Planned treatment with biological agents within 28 days prior to receiving
             TheraSphere (may resume after Y-90 treatment or immediately if in control arm)

          -  Planned liver directed therapy or radiation therapy

          -  Intervention for, or compromise of, the Ampulla of Vater

          -  Clinically evident ascites (trace ascites on imaging is acceptable)

          -  Toxicities due to prior cancer therapy that have not resolved before the initiation
             of study treatment, if the Investigator determines that the continuing complication
             will compromise the safe treatment of the patient

          -  Significant life-threatening extra-hepatic disease, including patients who are on
             dialysis, have unresolved diarrhea, have serious unresolved infections including
             patients who are known to be human immunodeficiency virus (HIV) positive or have
             acute hepatitis B virus (HBV) or hepatitis C virus (HCV)

          -  confirmed extra-hepatic metastases. Limited indeterminate extra-hepatic lesions in
             the lung and/or lymph nodes are permitted (up to 5 lesions in the lung, with each
             individual lesion &lt;1 cm; any number of lymph nodes with each individual nodes &lt;1.5
             cm)

          -  Contraindications to the planned second line standard-of-care chemotherapy regimen

          -  Women of childbearing potential must have a negative serum pregnancy test within 14
             days prior to randomization, and must not be breastfeeding and must agree to use
             contraceptive for duration of study.

          -  Participation in a clinical trial with an investigational therapy within 30 days
             prior to randomization

          -  Co-morbid disease or condition that would place the patient at undue risk and
             preclude safe use of TheraSphere treatment, in the Investigator's judgment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mary F Mulcahy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ricky Sharma, MA FRCP FRCR PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oxford</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nathan F Messinger</last_name>
    <phone>912.656.2696</phone>
    <email>Nathan.Messinger@chiltern.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Judith Koehnen</last_name>
    <phone>+49 (0)221-80068367</phone>
    <email>judith.Koehnen@Chiltern.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UCSF Helen Diller Family Comprehensive Cancer Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Curt Johanson</last_name>
      <phone>415-353-2310</phone>
      <email>curt.johanson@cc.ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Nicholas Fidelman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>George Washington University Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>University of Miami Miller School of Medicine, Florida</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Doris Martin</last_name>
      <phone>305-243-5491</phone>
      <email>dmartin3@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Lorraine Portelance, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Moffit Cancer Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Malesa Pereira</last_name>
      <phone>813-745-4090</phone>
      <email>malesa.pereira@moffitt.org</email>
    </contact>
    <investigator>
      <last_name>Nishi Kothari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlene del Castillo</last_name>
      <phone>312-695-1518</phone>
      <email>carlene.castillo@northwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Mary Mulcahy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Roche</last_name>
      <phone>312-563-2169</phone>
      <email>ashley_roche@rush.edu</email>
    </contact>
    <investigator>
      <last_name>Marisa Hill, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University School of Medicine</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamiko MaGee</last_name>
      <phone>317-278-7557</phone>
      <email>trmagee@iupui.edu</email>
    </contact>
    <investigator>
      <last_name>Matthew S Johnson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Schlegel</last_name>
      <phone>502-629-3383</phone>
      <email>melissa.schlegel@louisville.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Martin, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Lahey Clinic - Tufts University</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nanette Matrullo, MD</last_name>
      <phone>781-744-4290</phone>
      <email>nanette.matrullo@lahey.org</email>
    </contact>
    <investigator>
      <last_name>Shams Iqbal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debra Krease</last_name>
      <phone>734-764-6847</phone>
      <email>debraakr@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Mary Feng, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Karmanos Cancer Institute</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colette Zack</last_name>
      <phone>313-576-9385</phone>
      <email>zackc@karmanos.org</email>
    </contact>
    <investigator>
      <last_name>Phillip Phillip, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Mary's Healthcare</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy Estkowski</last_name>
      <phone>616-685-5156</phone>
      <email>estkowk@mercyhealth.com</email>
    </contact>
    <investigator>
      <last_name>Matthew A Tiede, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spectrum Health / Advanced Radiology Services</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Mohr, BSN,RN,CCRC</last_name>
      <phone>616-486-6111</phone>
      <email>kimberly.mohr@spectrumhealth.org</email>
    </contact>
    <investigator>
      <last_name>Manish Varma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Piper Cancer Institute, Abbott Northwestern Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Albers</last_name>
      <phone>612-863-9466</phone>
      <email>lisa.albers@allina.com</email>
    </contact>
    <investigator>
      <last_name>Joseph Leach, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>St Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robin Haverman</last_name>
      <phone>314-747-1624</phone>
      <email>havermanr@wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Darryl Zuckerman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Rochester, James P Wilmot Cancer Ctr</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie Koek</last_name>
      <phone>585-275-8213</phone>
      <email>Laurie_koek@urmc.rochester.edu</email>
    </contact>
    <investigator>
      <last_name>Marcus Noel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ihab Haddadin, MD</last_name>
      <phone>216-444-0405</phone>
      <email>haddadi@ccf.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clare Lane</last_name>
      <phone>216-445-9380</phone>
      <email>lanec@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Haddadin Ihab, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saba Elias</last_name>
      <email>saba.elias@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Hooman Khabiri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Miami Valley Hospital</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45409</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Garrett</last_name>
      <phone>937-208-3307</phone>
      <email>kjgarrett@PremierHealth.com</email>
    </contact>
    <investigator>
      <last_name>Shannon Kauffman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evelyn Stainthorpe, BS, CCRC</last_name>
      <phone>212-662-6983</phone>
      <email>evelyn.stainthorpe@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Michael C Soulen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Diagnostic Imaging Inc</name>
      <address>
        <city>Trevose</city>
        <state>Pennsylvania</state>
        <zip>19053</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sally Wagenborg, RN, CCRP</last_name>
      <phone>215-612-4881</phone>
      <email>swagenborg@ariahealth.org</email>
    </contact>
    <investigator>
      <last_name>Aaron Shiloh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UT Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Carrigan</last_name>
      <phone>214-645-2704</phone>
      <email>christina.carrigan@utsouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Anil Pillai, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cynthia Brown</last_name>
      <phone>713-792-2924</phone>
      <email>cbrown@mdanderson.org</email>
    </contact>
    <investigator>
      <last_name>Armeen Mahvash, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Marks Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84124</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melinda Turpin</last_name>
      <phone>801-831-0512</phone>
      <email>melinda.turpin@mountainstarhealth.com</email>
    </contact>
    <investigator>
      <last_name>James Carlisle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Virginia Health System</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Royanne Koogler</last_name>
      <phone>434-924-9496</phone>
      <email>RLB8Y@virginia.edu</email>
    </contact>
    <contact_backup>
      <last_name>Snjezana Zaja-Milatovic</last_name>
      <phone>434-243-6575</phone>
      <email>SZ7S@virginia.edu</email>
    </contact_backup>
    <investigator>
      <last_name>James Stone, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sentara Cancer Research</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Bowman</last_name>
      <phone>757-388-1926</phone>
      <email>ambowman@sentara.com</email>
    </contact>
    <investigator>
      <last_name>Harlan Vingan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie DiGiacomo</last_name>
      <phone>206-288-6358</phone>
      <email>sdigiaco@seattlecca.org</email>
    </contact>
    <investigator>
      <last_name>Siddharth Padia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>William P Harris, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gundersen Medical Foundation</name>
      <address>
        <city>La Crosse</city>
        <state>Wisconsin</state>
        <zip>54601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caryleigh Caryleigh</last_name>
      <phone>608-775-0852</phone>
      <email>cmrasmus@gundersenhealth.org</email>
    </contact>
    <investigator>
      <last_name>Azene Ezana, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin Hospital &amp; Clinics</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin, Inc.</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Weil</last_name>
      <phone>414-805-3028</phone>
      <email>eweil@mcw.edu</email>
    </contact>
    <investigator>
      <last_name>William Rilling, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1210</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johanna Moyes</last_name>
      <phone>0043-1-40 400-58900</phone>
      <email>johanna.moyses@akhwien.at</email>
    </contact>
    <investigator>
      <last_name>Loewe Christian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AZ - Sint Lucas Ziekemhuis</name>
      <address>
        <city>Gent</city>
        <state>Oost-Vlaander</state>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joline Goossens</last_name>
      <phone>0032 9 224 6227</phone>
      <email>Joline.Goossens@AZSTLUCAS.BE</email>
    </contact>
    <investigator>
      <last_name>Johan Van Ongeval, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VZW AZ Groeninge</name>
      <address>
        <city>Kortrijk</city>
        <zip>8500</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fien Verplancke</last_name>
      <phone>0032 566 33337</phone>
      <email>fien.verplancke@azgroeninge.be</email>
    </contact>
    <investigator>
      <last_name>Philippe Vergauwe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>QEII Health Services Center</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 3A7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorrie Yunace</last_name>
      <phone>902-473-6105</phone>
      <email>lorrie.yunace@nshealth.ca</email>
    </contact>
    <investigator>
      <last_name>Robert Abraham, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>London Regional Cancer Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 4L6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Malpage</last_name>
      <phone>519-685-8618</phone>
      <email>anne.malpage@lhsc.on.ca</email>
    </contact>
    <investigator>
      <last_name>Stephen Welch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheryl Geen-Smith</last_name>
      <phone>(416) 946-4501</phone>
      <phone_ext>6639</phone_ext>
      <email>cheryl.geen-smith@uhn.ca</email>
    </contact>
    <investigator>
      <last_name>John Beecroft, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McGill University Health Centre / Royal Victoria Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A 1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ayat Salman</last_name>
      <phone>(514) 934-1934</phone>
      <phone_ext>36237</phone_ext>
      <email>Ayat.Salman@MUHC.MCGILL.CA</email>
    </contact>
    <investigator>
      <last_name>Tatiana Cabrera, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hong Kong Sanatorium and Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janet Leung</last_name>
      <phone>852-2835-8877</phone>
      <email>janet.ky.leung@hksh.com</email>
    </contact>
    <investigator>
      <last_name>Thomas Leung, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queen Mary Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolyn Heung</last_name>
      <phone>852-2255-4216</phone>
      <email>heungkl@hku.hk</email>
    </contact>
    <investigator>
      <last_name>Victor Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinici of Imaging Methods - University Hospital Plzen</name>
      <address>
        <city>Plzen</city>
        <zip>30640</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>CHRU Montpellier - Hopital St Eloi - imagerie medical</name>
      <address>
        <city>Montpellier</city>
        <state>Cedex 5</state>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leslie Bouisset</last_name>
      <phone>003346733 9877</phone>
      <email>I-bouisset@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Boris Guiu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU d'Angers, Gastroenterologie, Endoscopie &amp; Oncologie digestive Médecine</name>
      <address>
        <city>Angers</city>
        <state>Cedex 9</state>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathanaelle Cornet</last_name>
      <phone>0033241356054</phone>
      <email>NaTrichereau@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>François-Xavier Caroli-Bosc, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse, Hôpital Rangueil</name>
      <address>
        <city>Toulouse</city>
        <state>Cedex 9</state>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline Gregoire</last_name>
      <phone>0033 5 61322188</phone>
      <email>gregoire.c@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Rosine Guimbaud, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Henri Mondor, Oncologie médical</name>
      <address>
        <city>Créteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia Francese</last_name>
      <phone>0033 1 49 81 41 64</phone>
      <email>julia.francese@hmn.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Christophe Tournigand, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hotel-Dieu, Service d'Hepatogastro-enterologie</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helene Auble</last_name>
      <phone>0033 2 40 08 75 03</phone>
      <email>Helene.AUBLE@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Yann Touchefeu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Nice, Hôpital de l'Archet, Radiology</name>
      <address>
        <city>Nice</city>
        <zip>6202</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvie Viano</last_name>
      <phone>0033492039001</phone>
      <email>mourgues.s@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Patrick Chevallier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital La Milétrie, CHU Poitiers, hépato gastroenterologie</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laetitia Rouleau</last_name>
      <phone>003354 9443044</phone>
      <email>laetitia.rouleau@chu-poitiers.fr</email>
    </contact>
    <investigator>
      <last_name>David Tougeron, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Eugene Marquis</name>
      <address>
        <city>Rennes</city>
        <zip>35042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gaelle Kergoat</last_name>
      <phone>33 299 25 32 61</phone>
      <email>g.kergoat@rennes.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Marc Pracht, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitaria di Bologna</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Rita Golfieri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gangnam Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yul Park</last_name>
      <phone>82-10-2352-6545</phone>
    </contact>
    <investigator>
      <last_name>Lee Kwang-Hun, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Korea University Anam Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyun Jin Park</last_name>
      <phone>82-2-920-6444</phone>
      <email>hioooih@naver.com</email>
    </contact>
    <investigator>
      <last_name>Yeul Hong Kim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuri Ko</last_name>
      <phone>82-10-3465-4369</phone>
      <email>gosima0225@naver.com</email>
    </contact>
    <investigator>
      <last_name>Tae-You Kim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seoung Hee Jung</last_name>
      <phone>82-10-2276-0943</phone>
      <email>shjung@yuhs.ac</email>
    </contact>
    <investigator>
      <last_name>TAE IL KIM, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyun-joo Ahn</last_name>
      <phone>82-10-9353-2903</phone>
      <email>susang2903@hanmail.net</email>
    </contact>
    <investigator>
      <last_name>Lee Myung Ah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National University Hospital Singapore</name>
      <address>
        <city>Singapore</city>
        <zip>119228</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Marban</last_name>
      <email>csimpc@nus.edu.sg</email>
    </contact>
    <investigator>
      <last_name>Thomas Soh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National University Hospital</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Partick Marban</last_name>
      <email>csimpc@nus.edu.sg</email>
    </contact>
    <investigator>
      <last_name>Thomas Soh Peng, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Puerta de Hierro</name>
      <address>
        <city>Majadahonda</city>
        <state>Madrid</state>
        <zip>28220</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rocio Navarro</last_name>
      <phone>0034 911 917 418</phone>
      <email>rocio.navarro@salud.madrid.org</email>
    </contact>
    <investigator>
      <last_name>Ana Ruiz Casado, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramon y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Carrera</last_name>
      <email>cristina.carrera.hryc@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Carmen Guillen Ponce, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital &quot;Fundacion Jimenez Diaz&quot;</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margarita Lobo</last_name>
      <phone>34 915 504 800</phone>
      <phone_ext>2299</phone_ext>
      <email>mlobo@fjd.es</email>
    </contact>
    <investigator>
      <last_name>Ana Leon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario Gregorio Maronon</name>
      <address>
        <city>Mardid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Corcuera Sánchez</last_name>
      <phone>914 269 394</phone>
      <email>acorcuera.hgugm@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Pilar-Garcia Alfonso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitaario Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <zip>33011</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cecilia Gonzalez</last_name>
      <phone>0034 985106100 Ext.36281</phone>
      <email>ceciliagonzalezd@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Jose-Maria Vieitez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Lozano Blesa, Zaragoza</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabel Huércanos</last_name>
      <phone>0034 976 76 57 69</phone>
      <email>ihuercanos@iisaragon.es</email>
    </contact>
    <investigator>
      <last_name>Maria-Pilar Emperador-Escudero, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Churchill Hospital</name>
      <address>
        <city>Oxford</city>
        <state>England</state>
        <zip>OX3 7LE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anju Chalin</last_name>
      <phone>0044 1865 235309</phone>
      <email>trialadministrator07@oncology.ox.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Ricky Sharma</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Edinburgh Cancer Centre - Western General Hospital</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH4 2XU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Moira Stewart</last_name>
      <phone>0131 537 2201</phone>
      <email>moira.stewart11@ed.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Ewan Brown, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Surrey County Hospital</name>
      <address>
        <city>Guildford</city>
        <zip>GU2 7XX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ceri Jamieson</last_name>
      <phone>0148 340 66 12</phone>
      <email>cerijamieson@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Tony Dhillon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University College London Hospitals Foundation NHS Trust</name>
      <address>
        <city>London</city>
        <zip>NW1 2BU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Wanstall</last_name>
      <phone>020 344 75103</phone>
      <email>Christopher.Wanstall@uclh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Steve Bandula, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guy's Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 9RT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorna Caplis</last_name>
      <phone>020 7188 8718</phone>
      <email>loma.caplis@gstt.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Paul Ross, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Christie, Manchester</name>
      <address>
        <city>Manchester</city>
        <zip>M20 4BX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Royle</last_name>
      <phone>0161 446 8344</phone>
      <email>julie.royle@christie.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Gregory Wilson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Newcastle upon Tyne Hospitals NHS Foundation Trust</name>
      <address>
        <city>Newcastle</city>
        <zip>NE7 7DN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Stoddart</last_name>
      <phone>0191 213 8439</phone>
      <email>Jonathan.Stoddart@nuth.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Ashraf Azzabi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nottingham University Hospital NHS Trust</name>
      <address>
        <city>Nottingham</city>
        <zip>NG5 1PB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jackie Worville</last_name>
      <phone>0115 969 1169</phone>
      <phone_ext>54692</phone_ext>
      <email>jackie.worville@nuh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Jamie Mills, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Western Park Hospital - Sheffield Teaching Hospitals Trial Center</name>
      <address>
        <city>Sheffield</city>
        <zip>NW3 2QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alison Redfearn</last_name>
      <phone>0044 114 226 51 60</phone>
      <email>a.redfearn@sheffield.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Joanne Hornbuckle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Southampton, Southampton General Hospital</name>
      <address>
        <city>Southampton</city>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liane Davis</last_name>
      <phone>023 81 208448</phone>
      <email>L.Davis@soton.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Andrew Bateman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>China</country>
    <country>Czech Republic</country>
    <country>France</country>
    <country>Italy</country>
    <country>Korea, Republic of</country>
    <country>Singapore</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <lastchanged_date>September 15, 2016</lastchanged_date>
  <firstreceived_date>November 24, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
